ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2015 American Transplant Congress

    T-Cell Mediated Vascular Rejection Can Be Identified By the Combined Measurement of Five Specific microRNAs in Blood

    M. Matz,1 K. Fabritius,1 C. Lorkowski,1 M. Dürr,1 J. Gaedeke,1 P. Durek,2 J. Grün,2 A. Goestemeyer,1 F. Bachmann,1 K. Wu,1 B. Rudolph,1 U. Weber,1 C. Haftmann,2 N. Unterwalder,3 N. Lachmann,1 A. Radbruch,2 H.-H. Neumayer,1 M.-F. Mashreghi,2 K. Budde.1

    1University Medicine Charité, Berlin, Germany; 2German Rheumatism Research Centre, Berlin, Germany; 3Labor Berlin GmbH, Berlin, Germany.

    MicroRNAs hold important roles in the regulation of gene expression. Their function has been correlated with kidney disease and they might represent a new class…
  • 2015 American Transplant Congress

    Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

    G. Zeng, Y. Huang, P. Randhawa.

    Pathology, University of Pittsburgh, Pittsburgh, PA.

    Histopathology cannot determine whether T-cell infiltrates in renal allograft biopsies recognize donor HLA or BKV antigens. The ability of a T-cell to respond in an…
  • 2015 American Transplant Congress

    DQB1 Epitope Matching Predicts the Development of De Novo DSA and Antibody Mediated Rejection

    M. Willicombe,1 M. Blow,2 P. Brookes,2 E. Santos,2 D. Taube.1

    1Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom; 2H&I, Hammersmith Hospital, London, United Kingdom.

    HLA DQ antibodies are the commonest de novo [DN] DSA specificity seen post renal transplantation. Their presence is associated with antibody mediated injury and allograft…
  • 2015 American Transplant Congress

    Delayed Graft Function in Patients Receiving Alemtuzumab Induction Therapy

    M. Shindorf,1 D. Fumo,1 M. Weis,1 W. Qu,1 M. Rees,1,2 J. Ortiz.1

    1The University of Toledo Medical Center, Toledo, OH; 2The Alliance for Paired Donation, Maumee, OH.

    Alemtuzumab (Campath 1-H) is a humanized monoclonal antibody directed at the CD52 glycoprotein that is becoming more prevalent as a choice for induction. Delayed graft…
  • 2015 American Transplant Congress

    Treatment of Hypertrophic Osteoarthropathy in an Intestinal Transplant Patient After Acute Cellular Rejection

    M. Keck.

    Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, NE.

    Background:Hypertrophic osteoarthropathy involves abnormal proliferation of bone at distal extremities. It involves clubbing, periostitis of tubular bones and synovial effusions. Some causes of secondary hypertrophic…
  • 2015 American Transplant Congress

    Non-Inferiority of Graft Survival of Living Unrelated Kidney Transplant compared to Living Related Kidney Transplant as Analyzed by First Degree Relative

    A. Patel, M. Goggins, D. Kim, P. Rohini, L. Malinzak.

    Henry Ford Transplant Institute, Detroit, MI.

    The perceived advantage of donating a kidney directly to a family member is difficult to uncouple in the setting of voluntary exchange or other kidney…
  • 2015 American Transplant Congress

    Transplant Glomerulopathy in a Novel Model of Chronic Antibody Mediated Rejection Is Associated With DSA and Glomerular IgM

    S. Panzer,1 S. Reese,1 N. Wilson Schlei,1 W. Zhong,2 A. Djamali.1

    1Medicine, University of Wisconsin Madison, Madison, WI; 2Pathology, University of Wisconsin Madison, Madison, WI.

    PurposeChronic active antibody mediated rejection (cAMR) and transplant glomerulopathy (TG) are major determinants of long-term allograft survival. However, the contribution of DSA and glomerular immunoglobulins…
  • 2015 American Transplant Congress

    Does Switching Predict Conversion: IgM De Novo Donor Specific HLA Antibodies Class Switch to IgG in Subclinical Antibody Mediated Rejection in Heart Transplant Recipients

    M. Askar,1 R. Rodriguez,1 L. Klingman,1 D. Thomas,1 A. Zhang,1 H. Morf,2 N. Hamon,1 N. Moazami,1 E. Hsich,1 D. Taylor,1 R. Starling,1 C. Tan.1

    1Cleveland Clinic, Cleveland; 2School of Medicine, Leipzig University, Leipzig, Germany.

    Background: Concomitant C4d and C3d detection in heart biopsies correlates with circulating DSA and graft dysfunction. Detection of C4d only in surveillance biopsies is not…
  • 2015 American Transplant Congress

    An Orchestrated Sequence of Innate and Adaptive Immune Responses Is Associated With Rejection After Pediatric Liver Transplantation

    C. Falk,1 I. Goldschmidt,2 F. Mutschler,2 C. Neudörfl,1 J. Keil,1 K. Daemen,1 F. Lehner,3 R. Mikolajzcyk,4 A. Karch,4 U. Baumann.2

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Division of Pediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany; 3Department of Visceral General and Transplant Surgery, Hannover Medical School, Hannover, Germany; 4Department of Epidemiology, Helmholtz Center for Infection Research, HZI, Braunschweig, Braunschweig, Germany.

    The concept of a coordinated immune response initiated by innate and sustained by adaptive immune cells and their soluble mediators is well established for infection…
  • 2015 American Transplant Congress

    The Clinical Outcome of Plasma Cell-Rich Rejection of Kidney Allograft

    J. Hasegawa,1 K. Honda,2 S. Wakai,1 H. Shirakawa,3 M. Okumi,3 K. Omoto,3 H. Ishida,3 K. Tanabe.3

    1Nephrology, Ohkubo Hospital, Tokyo, Japan; 2Pathology, Tokyo Women's Medical University, Tokyo, Japan; 3Urology, Tokyo Women's Medical University, Tokyo, Japan.

    Background: Plasma cell-rich rejection (PCRR) is a rare type of allograft rejection characterized by the presence of mature plasma cells. This type of rejection has…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences